RBC Bioscience

RBC Bioscience ROCE

The Return on Capital Employed (ROCE) of RBC Bioscience (6848.TWO) as of Nov 5, 2026 is 14.36 %. In the previous year, Return on Capital Employed (ROCE) was 6.04 % — a change of 137.74% (higher).

ROCE

14.36 %

YoY

137.74%

Last updated:

In 2024, RBC Bioscience's return on capital employed (ROCE) was 14.36 %, a 137.74% increase from the 6.04 % ROCE in the previous year.

The RBC Bioscience ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
16.49 TWD
Jan 1, 2019
11.23 TWD
Jan 1, 2020
107.81 TWD
Jan 1, 2021
18.93 TWD
Jan 1, 2022
3.11 TWD
Jan 1, 2023
6.04 TWD
Jan 1, 2024
14.36 TWD
The RBC Bioscience ROCE history
YEARROCEYoY
14.36 %+137.74%
6.04 %+93.92%
3.11 %-83.54%
18.93 %-82.44%
107.81 %+860.02%
11.23 %-31.90%
16.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling RBC Bioscience's Return on Capital Employed (ROCE)

RBC Bioscience's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing RBC Bioscience's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

RBC Bioscience's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in RBC Bioscience’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about RBC Bioscience stock

Return on Capital Employed (ROCE) of RBC Bioscience is 14.36 % in 2024.

Return on Capital Employed (ROCE) of RBC Bioscience changed from 6.04 % to 14.36 %, representing a 137.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s RBC Bioscience with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — RBC Bioscience

All Key Metrics — RBC Bioscience